Hepatocyte growth factor modification enhances the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cells

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhang, Jian ^a   Wang, Lin Lin ^a   Du, Wei ^a   Yu, Yi Chao ^a   Ju, Wei Zhu ^a   Man, Yi Long ^a   Li, Xiao Rong ^a   Chen, Yan ^a   Wang, Zi Dun ^a   Gu, Wei Juan ^a   Zhang, Feng Xiang ^a   Wang, Hua ^b   Wu, Chu Tse ^b   Cao, Ke Jiang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; NEUROMODULIN; SCATTER FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOMETRICS; NONHUMAN; PROTEIN EXPRESSION; SCATTER FACTOR GENE; SYMPATHETIC NERVE; WESTERN BLOTTING; ANGIOGENESIS; ANIMAL; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; BONE MARROW CELL; CELL SURVIVAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART VENTRICLE; MESENCHYMAL STROMA CELL; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PIG;

ANIMALS; APOPTOSIS; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; BONE MARROW CELLS; CELL SURVIVAL; ELECTRIC STIMULATION; GENE EXPRESSION REGULATION; HEART VENTRICLES; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; SWINE;

EID: 84909986752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111246     Document Type: Article

References (43)

1. Myerburg RJ, Castellanos A (2006) Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart rhythm: the official journal of the Heart Rhythm Society 3: 235-239.
2. Mills WR, Mal N, Kiedrowski MJ, Unger R, Forudi F, et al. (2007) Stem cell therapy enhances electrical viability in myocardial infarction. Journal of molecular and cellular cardiology 42: 304-314.
3. Wang D, Zhang F, Shen W, Chen M, Yang B, et al. (2011) Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. International journal of cardiology 152: 314-320.
4. Lee K, Majumdar MK, Buyaner D, Hendricks JK, Pittenger MF, et al. (2001) Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Molecular therapy: the journal of the American Society of Gene Therapy 3: 857-866.
5. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature medicine 9: 1195-1201.
6. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S (1997) Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 95: 2552-2558.
7. Lohr JW, Lee TP, Farooqui M, Mookerjee BK (2000) Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease. Journal of medicine 31: 131-141.
8. Funatsu T, Sawa Y, Ohtake S, Takahashi T, Matsumiya G, et al. (2002) Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor. The Journal of thoracic and cardiovascular surgery 124: 1099-1105.
9. Liu HJ, Duan HF, Lu ZZ, Wang H, Zhang QW, et al. (2005) Influence of hepatocyte growth factor on biological characteristics of bone marrow-derived mesenchymal stem cells. Zhongguo shi yan xue ye xue za zhi 13: 1044-1048.
10. Ha X, Dong F, Lv T (2010) Modification and activity observation of hepatocyte growth factor gene on bone marrow mesenchymal stem cells. Zhongguo xiu fu chong jian wai ke za zhi 24: 613-617.
11. Duan HF, Wu CT, Wu DL, Lu Y, Liu HJ, et al. (2003) Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Molecular therapy: the journal of the American Society of Gene Therapy 8: 467-474.
12. Bian L, Guo Z-K, Ai H-S, Wang H, Meng E-H, et al. (2006) Hepatocyte growth factor gene modification enhancing immunosuppressive activity of human bone marrow-derived mesenchymal stem cells. Bull Acad Mil Med Sci 30: 323-328 (in Chinese).
13. Bian L, Guo ZK, Wang HX, Wang JS, Wang H, et al. (2009) In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. In Vivo 23: 21-27.
14. Wang H, Yang YF, Zhao L, Xiao FJ, Zhang QW, et al. (2013) Hepatocyte growth factor gene-modified mesenchymal stem cells reduce radiation-induced lung injury. Hum Gene Ther 24: 343-353.
15. Franz MR, Flaherty JT, Platia EV, Bulkley BH, Weisfeldt ML (1984) Localization of regional myocardial ischemia by recording of monophasic action potentials. Circulation 69: 593-604.
16. Billman GE (2009) Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training. American journal of physiology Heart and circulatory physiology 297: H1171-1193.
17. Thayer JF, Yamamoto SS, Brosschot JF (2010) The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. International journal of cardiology 141: 122-131.
18. Reinecke H, Zhang M, Bartosek T, Murry CE (1999) Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100: 193-202.
19. Teng CJ, Luo J, Chiu RC, Shum-Tim D (2006) Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. The Journal of thoracic and cardiovascular surgery 132: 628-632.
20. Maurel As, Azarnoush K, Sabbah L, Vignier N, Le Lorch M, et al. (2005) Can Cold or Heat Shock Improve Skeletal Myoblast Engraftment in Infarcted Myocardium? Transplantation 80: 660-665.
21. Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, et al. (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: II247-256.
22. Davani S, Marandin A, Mersin N, Royer B, Kantelip B, et al. (2003) Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 Suppl 1: II253-258.
23. Zhang F, Song G, Li X, Gu W, Shen Y, et al. (2014) Transplantation of iPSc Ameliorates Neural Remodeling and Reduces Ventricular Arrhythmias in a Post-Infarcted Swine Model. J Cell Biochem 115: 531-539.
24. Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM (1997) The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90: 315-323.
25. Frisch SM, Vuori K, Kelaita D, Sicks S (1996) A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. The Journal of cell biology 135: 1377-1382.
26. Pinto JM, Boyden PA (1999) Electrical remodeling in ischemia and infarction. Cardiovascular research 42: 284-297.
27. Roell W, Lewalter T, Sasse P, Tallini YN, Choi BR, et al. (2007) Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450: 819-824.
28. Kuhlmann MT, Kirchhof P, Klocke R, Hasib L, Stypmann J, et al. (2006) GCSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. The Journal of experimental medicine 203: 87-97.
29. Fernandes S, Amirault JC, Lande G, Nguyen JM, Forest V, et al. (2006) Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovascular research 69: 348-358.
30. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, et al. (2001) Conduction slowing and sudden arrhythmic death in mice with cardiacrestricted inactivation of connexin43. Circulation research 88: 333-339.
31. Nori SL, Gaudino M, Alessandrini F, Bronzetti E, Santarelli P (1995) Immunohistochemical evidence for sympathetic denervation and reinnervation after necrotic injury in rat myocardium. Cell Mol Biol (Noisy-le-grand) 41: 799-807.
32. Chen PS, Chen LS, Cao JM, Sharifi B, Karagueuzian HS, et al. (2001) Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovascular research 50: 409-416.
33. Oh YS, Jong AY, Kim DT, Li H, Wang C, et al. (2006) Spatial distribution of nerve sprouting after myocardial infarction in mice. Heart rhythm: the official journal of the Heart Rhythm Society 3: 728-736.
34. Bocchi L, Savi M, Graiani G, Rossi S, Agnetti A, et al. (2011) Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. PloS one 6: e17750.
35. Ajijola OA, Yagishita D, Patel KJ, Vaseghi M, Zhou W, et al. (2013) Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: neural remodeling in a spatial context. American journal of physiology Heart and circulatory physiology 305: H1031-1040.
36. Billman GE (2006) A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Pharmacology & therapeutics 111: 808-835.
37. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, et al. (2000) Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 101: 1960-1969.
38. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, et al. (2000) Nerve sprouting and sudden cardiac death. Circulation research 86: 816-821.
39. Rubart M, Zipes DP (2005) Mechanisms of sudden cardiac death. The Journal of clinical investigation 115: 2305-2315.
40. Held P, Yusuf S (1989) Early intravenous beta-blockade in acute myocardial infarction. Cardiology 76: 132-143.
41. Falcone C (2005) Rapid Heart Rate Increase at Onset of Exercise Predicts Adverse Cardiac Events in Patients With Coronary Artery Disease. Circulation 112: 1959-1964.
42. Kocovic DZ, Harada T, Friedman PL, Stevenson WG (1999) Characteristics of electrograms recorded at reentry circuit sites and bystanders during ventricular tachycardia after myocardial infarction. Journal of the American College of Cardiology 34: 381-388.
43. Tung R, Mathuria N, Michowitz Y, Yu R, Buch E, et al. (2012) Functional pace-mapping responses for identification of targets for catheter ablation of scar-mediated ventricular tachycardia. Circ Arrhythm Electrophysiol 5: 264-272.